These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Susceptibility of Anopheles gambiae from Côte d'Ivoire to insecticides used on insecticide-treated nets: evaluating the additional entomological impact of piperonyl butoxide and chlorfenapyr. Kouassi BL; Edi C; Tia E; Konan LY; Akré MA; Koffi AA; Ouattara AF; Tanoh AM; Zinzindohoue P; Kouadio B; Andre M; Irish SR; Armistead J; Dengela D; Cissé NG; Flatley C; Chabi J Malar J; 2020 Dec; 19(1):454. PubMed ID: 33298071 [TBL] [Abstract][Full Text] [Related]
4. Temperature, mosquito feeding status and mosquito density influence the measured bio-efficacy of insecticide-treated nets in cone assays. Mseti JJ; Maasayi MS; Lugenge AG; Mpelepele AB; Kibondo UA; Tenywa FC; Odufuwa OG; Tambwe MM; Moore SJ Parasit Vectors; 2024 Mar; 17(1):159. PubMed ID: 38549097 [TBL] [Abstract][Full Text] [Related]
5. Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa. Gleave K; Lissenden N; Richardson M; Choi L; Ranson H Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012776. PubMed ID: 30488945 [TBL] [Abstract][Full Text] [Related]
6. Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa. Gleave K; Lissenden N; Chaplin M; Choi L; Ranson H Cochrane Database Syst Rev; 2021 May; 5(5):CD012776. PubMed ID: 34027998 [TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of two pyrethroid-piperonyl butoxide nets (Olyset Plus and PermaNet 3.0) against pyrethroid resistant malaria vectors: a non-inferiority assessment. Ngufor C; Fagbohoun J; Agbevo A; Ismail H; Challenger JD; Churcher TS; Rowland M Malar J; 2022 Jan; 21(1):20. PubMed ID: 35016676 [TBL] [Abstract][Full Text] [Related]
8. Insecticide susceptibility status of Anopheles gambiae mosquitoes and the effect of pre-exposure to a piperonyl butoxide (PBO) synergist on resistance to deltamethrin in northern Namibia. Joseph RN; Mwema T; Eiseb SJ; Maliti DV; Tambo M; Iitula I; Eloff L; Lukubwe O; Smith-Gueye C; Vajda ÉA; Tatarsky A; Katokele ST; Uusiku PN; Walusimbi D; Ogoma SB; Mumbengegwi DR; Lobo NF Malar J; 2024 Mar; 23(1):77. PubMed ID: 38486288 [TBL] [Abstract][Full Text] [Related]
9. Evidence supporting deployment of next generation insecticide treated nets in Burkina Faso: bioassays with either chlorfenapyr or piperonyl butoxide increase mortality of pyrethroid-resistant Anopheles gambiae. Hien AS; Soma DD; Maiga S; Coulibaly D; Diabaté A; Belemvire A; Diouf MB; Jacob D; Koné A; Dotson E; Awolola TS; Oxborough RM; Dabiré RK Malar J; 2021 Oct; 20(1):406. PubMed ID: 34663348 [TBL] [Abstract][Full Text] [Related]
10. Comparative assessment of insecticide resistance phenotypes in two major malaria vectors, Anopheles funestus and Anopheles arabiensis in south-eastern Tanzania. Pinda PG; Eichenberger C; Ngowo HS; Msaky DS; Abbasi S; Kihonda J; Bwanaly H; Okumu FO Malar J; 2020 Nov; 19(1):408. PubMed ID: 33176805 [TBL] [Abstract][Full Text] [Related]
11. Comparison of cone bioassay estimates at two laboratories with different Anopheles mosquitoes for quality assurance of pyrethroid insecticide-treated nets. Mbwambo SG; Bubun N; Mbuba E; Moore J; Mbina K; Kamande D; Laman M; Mpolya E; Odufuwa OG; Freeman T; Karl S; Moore SJ Malar J; 2022 Jul; 21(1):214. PubMed ID: 35799172 [TBL] [Abstract][Full Text] [Related]
12. Can the performance of pyrethroid-chlorfenapyr nets be reduced when combined with pyrethroid-piperonyl butoxide (PBO) nets? Syme T; Nounagnon J; N'dombidjé B; Gbegbo M; Agbevo A; Ahoga J; Ngufor C Malar J; 2023 Jul; 22(1):214. PubMed ID: 37480030 [TBL] [Abstract][Full Text] [Related]
13. Multi-country evaluation of the durability of pyrethroid plus piperonyl-butoxide insecticide-treated nets: study protocol. Mbuba E; Odufuwa OG; Moore J; Mmbaga S; Tchicaya E; Edi C; Chalageri V; Uragayala S; Sharma A; Rahi M; Raghavendra K; Eapen A; Koenker H; Ross A; Moore SJ Malar J; 2023 Jan; 22(1):30. PubMed ID: 36707886 [TBL] [Abstract][Full Text] [Related]
14. Bio-efficacy and physical integrity of piperonylbutoxide coated combination net (PermaNet Birhanu A; Asale A; Yewhalaw D Malar J; 2019 Jul; 18(1):224. PubMed ID: 31272452 [TBL] [Abstract][Full Text] [Related]
15. Emerging Mosquito Resistance to Piperonyl Butoxide-Synergized Pyrethroid Insecticide and Its Mechanism. Zhou G; Li Y; Jeang B; Wang X; Cummings RF; Zhong D; Yan G J Med Entomol; 2022 Mar; 59(2):638-647. PubMed ID: 35050361 [TBL] [Abstract][Full Text] [Related]
16. Personal protection with PBO-pyrethroid synergist-treated nets after 2 years of household use against pyrethroid-resistant Anopheles in Tanzania. Martin JL; Mosha FW; Lukole E; Rowland M; Todd J; Charlwood JD; Mosha JF; Protopopoff N Parasit Vectors; 2021 Mar; 14(1):150. PubMed ID: 33691742 [TBL] [Abstract][Full Text] [Related]
17. Video augmentation of the WHO cone assay to quantify mosquito behavioural responses to insecticide-treated nets. Jones J; Matope A; Barreaux P; Gleave K; Steen K; Ranson H; McCall PJ; Foster GM Parasit Vectors; 2023 Nov; 16(1):420. PubMed ID: 37968752 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of an alpha-cypermethrin + PBO mixture long-lasting insecticidal net VEERALIN® LN against pyrethroid resistant Anopheles gambiae s.s.: an experimental hut trial in M'bé, central Côte d'Ivoire. Oumbouke WA; Rowland M; Koffi AA; Alou LPA; Camara S; N'Guessan R Parasit Vectors; 2019 Nov; 12(1):544. PubMed ID: 31730481 [TBL] [Abstract][Full Text] [Related]
19. Complete series method (CSM): a convenient method to reduce daily heterogeneity when evaluating the regeneration time (RT) of insecticide-treated nets (ITNs). Lugenge AG; Odufuwa OG; Mseti JJ; Swai JK; Skovmand O; Moore SJ Parasit Vectors; 2024 May; 17(1):235. PubMed ID: 38778423 [TBL] [Abstract][Full Text] [Related]
20. An observational analysis of the impact of deltamethrin + piperonyl butoxide insecticide-treated nets on malaria case incidence and entomological indicators in Ebonyi State, Nigeria, 2017-2021. Davis KM; Okoko OO; Oduola AO; Inyama PU; Uneke CJ; Ambrose K; Seyoum A; Uhomoibhi P; Rhoda DA; Clary CB; Millar J; Littrell M; Rogers JH; Yoshimizu M; Inyang U; Maire M; Burnett SM Malar J; 2024 Oct; 23(1):317. PubMed ID: 39427181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]